Application of imatinib and derivative thereof and analgesic in combined medication or compound preparation in treatment of pain
A derivative and analgesic technology, applied in pharmaceutical formulations, drug combinations, medical preparations containing active ingredients, etc. It can solve problems such as weak effect, and achieve the effect of solving clinical pain treatment problems, preventing serious side effects, and expanding clinical indications.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Embodiment 1: The effect of imatinib mesylate and morphine dose ratio on the formation of rat morphine addiction and its molecular mechanism Effects of Addiction Formation
[0046] 1. Materials
[0047] Drugs: morphine (Morphine, Qinghai Pharmaceutical Factory), imatinib mesylate (Selleck Chemicals).
[0048] Experimental animals: SPF grade SD male rats, weighing 180-220g. Provided by Hunan Slake Jingda Experimental Animal Experiment Co., Ltd., the animal certificate number is NO.43004700040706, and the production license number is SCXK (Xiang) 2016-0002. Rat feed was purchased from the Experimental Animal Center of Wuhan University.
[0049] Experimental instrument: conditional position preference instrument (developed by Institute of Materia Medica, Chinese Academy of Medical Sciences): the experiment adopts computer automatic control. The apparatus is a conditioned place preference chamber consisting of three chambers: two side chambers and a middle chamber. The...
Embodiment 2
[0065] Example 2: Influence of the dose-matching effect of imatinib mesylate and morphine on the formation of addiction to morphine during analgesia
[0066] It can be seen from Example 1 that imatinib and its derivative imatinib mesylate inhibit the formation of morphine addiction in rats by inhibiting the phosphorylation activity of c-kit in the nucleus accumbens region, and opioids such as morphine are clinically Commonly used analgesic drugs in the world, the dosage ratio of the two is greater than or equal to 2:1, which can prevent and treat the side effects of morphine addiction. In this embodiment, imatinib mesylate and morphine are selected as the analgesic for acute visceral pain caused by acetic acid in mice Drugs, by establishing an experimental model of acetic acid-induced pain in mice and a conditioned place preference experimental model, to explore the effect of the dose ratio effect of imatinib mesylate and morphine on the formation of morphine addiction in mice ...
Embodiment 3
[0077] Example 3: Effect of imatinib mesylate on morphine tolerance in rats
[0078] From the results of Examples 1 and 2, it can be seen that the imatinib mesylate and morphine composition greater than or equal to a dose ratio of 2:1 can obviously prevent the formation of morphine addiction in rats or mice, and the present embodiment selects mesylate Imatinib mesylate and morphine are used as analgesic drugs for central pain in rats. Through the establishment of morphine tolerance and hot plate pain models in rats, the effects of combined administration and compound administration of imatinib mesylate and morphine on morphine tolerance were investigated. influenced by.
[0079] 1. Materials
[0080] Drugs: morphine (Qinghai Pharmaceutical Factory); imatinib mesylate (Selleck Chemicals).
[0081] Experimental animals: SPF grade SD female rats, weighing 180-220g. Provided by the Experimental Animal Center of China Three Gorges University, the animal certificate number is NO....
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com